Wildcat Capital Management LLC 13D and 13G filings for Silexion Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-26 4:15 pm Purchase |
2025-06-26 | 13D | Silexion Therapeutics Ltd. SLXN |
Wildcat Capital Management LLC | 113,428 1.300% |
113,428 (New Position) |
Filing |